<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37379227</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1502-7686</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Scandinavian journal of clinical and laboratory investigation</Title><ISOAbbreviation>Scand J Clin Lab Invest</ISOAbbreviation></Journal><ArticleTitle>Validation of an indirect ELISA assay for assessment of autoantibodies against full-length TRIM21 and its individual domains.</ArticleTitle><Pagination><StartPage>309</StartPage><EndPage>317</EndPage><MedlinePgn>309-317</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/00365513.2023.2221862</ELocationID><Abstract><AbstractText>Anti-SSA-autoantibodies are common in patients with rheumatologic disease, especially Sj&#xf6;gren's syndrome, systemic lupus erythematosus and rheumatoid arthritis. They consist of both autoantibodies towards Ro60 and Ro52, the latter also known as TRIM21. TRIM21 is an intracellular protein consisting of four domains; PRY/SPRY, Coiled-Coil, B-box and RING. The aim of this study was to establish an indirect ELISA detecting autoantibodies towards both the full-length TRIM21 protein and its four domains. We expressed the five constructs, created, and validated indirect ELISA protocols for each target using plasma from anti-SSA positive patients and healthy controls. Our findings were validated to the clinically used standards. We measured significantly higher levels of autoantibodies towards our full-length TRIM21, and the PRY/SPRY, Coiled-Coil and RING domains in patients compared to healthy controls. No significant difference in the level of autoantibodies were detected against the B-box domain. Our setups had a signal to noise ratio in the range of 30 to 184, and an OD between 2 and 3. Readings did not decline using NaCl of 500&#x2009;mM as wash, affirming the high binding affinity of the autoantibodies measured. Our protocols allow us to further study the different autoantibodies of anti-SSA positive patients. This creates the possibility to stratify our patients into subgroups regarding autoantibody profile and specific pheno- or endotype.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dahl</LastName><ForeName>Marie Louise N&#xe6;stholt</ForeName><Initials>MLN</Initials><Identifier Source="ORCID">0000-0003-2138-2477</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikkelsen</LastName><ForeName>Jakob Hauge</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0002-2914-3297</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hvid</LastName><ForeName>Malene</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3602-4261</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korsholm</LastName><ForeName>Trine-Line</ForeName><Initials>TL</Initials><Identifier Source="ORCID">0000-0001-7132-5978</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Kirstine Overgaard</ForeName><Initials>KO</Initials><Identifier Source="ORCID">0000-0003-3185-9611</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Christian Brix Folsted</ForeName><Initials>CBF</Initials><Identifier Source="ORCID">0000-0001-6182-2436</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greisen</LastName><ForeName>Stinne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2922-3307</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deleuran</LastName><ForeName>Bent</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7079-1587</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Scand J Clin Lab Invest</MedlineTA><NlmUniqueID>0404375</NlmUniqueID><ISSNLinking>0036-5513</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ELISA validation</Keyword><Keyword MajorTopicYN="N">Sj&#xf6;gren&#x2019;s syndrome</Keyword><Keyword MajorTopicYN="N">TRIM21</Keyword><Keyword MajorTopicYN="N">anti-Ro52-autoantibodies</Keyword><Keyword MajorTopicYN="N">anti-SSA-autoantibodies</Keyword><Keyword MajorTopicYN="N">autoantibodies</Keyword><Keyword MajorTopicYN="N">autoimmune disease</Keyword><Keyword MajorTopicYN="N">congenital AV-block</Keyword><Keyword MajorTopicYN="N">indirect ELISA</Keyword><Keyword MajorTopicYN="N">rheumatology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>12</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37379227</ArticleId><ArticleId IdType="doi">10.1080/00365513.2023.2221862</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>